ClinicalTrials.Veeva

Menu

Running Title: PPAR-γ, RXR-α, and VDR Expressions in Periodontitis

T

Tokat Gaziosmanpasa University

Status

Unknown

Conditions

Periodontitis

Treatments

Diagnostic Test: Gingiva Biopsy Sampling

Study type

Observational

Funder types

Other

Identifiers

NCT04018144
Gaziosmanpasa University Per

Details and patient eligibility

About

Objective: The present study aimed to determine the expressions of nuclear receptors PPAR (Peroxisome proliferative activator receptor)-γ, RXR (Retinoid X receptor)-α, and vitamin D receptor (VDR) in healthy volunteers and periodontitis patients with different grade involvement.

Methods: Group-1; healthy individuals, Group-2; periodontitis patients-stage 3 grade B, (H-GradeB), Group-3; periodontitis patients-stage 3 grade C, (D-GradeC). Clinical parameters as plaque index (PI), gingival index (GI) and clinical attachment levels (CAL) were measured. Fibroblast and inflammatory cells, PPAR-γ, RXR-α, and VDR levels were determined in histological slides.

Enrollment

45 estimated patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • systemic health
  • no drug use
  • no previous periodontal treatment within six months
  • no tobacco use

Exclusion criteria

  • pregnant or lactating women
  • patients used antibiotics in the last 6 months

Trial design

45 participants in 3 patient groups

Group-1
Description:
Healthy individuals
Treatment:
Diagnostic Test: Gingiva Biopsy Sampling
Group-2
Description:
Periodontitis patients-stage 3-grade B
Treatment:
Diagnostic Test: Gingiva Biopsy Sampling
Group-3
Description:
Periodontitis patients-stage 3-grade C
Treatment:
Diagnostic Test: Gingiva Biopsy Sampling

Trial contacts and locations

1

Loading...

Central trial contact

Ozkan KARATAS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems